AVADEL PHARMACEUTICALS PLC·4

Aug 2, 4:21 PM ET

Thornton Peter J. 4

4 · AVADEL PHARMACEUTICALS PLC · Filed Aug 2, 2018

Insider Transaction Report

Form 4
Period: 2018-08-01
Transactions
  • Award

    ADSs

    2018-08-01+27,90033,055 total
Holdings
  • Stock Option (right to buy)

    Exercise: $10.51From: 2018-06-28Exp: 2022-06-28ADSs (35,000 underlying)
    35,000
Footnotes (3)
  • [F1]The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
  • [F2]Represents 27,900 restricted ADSs granted under the issuer's Omnibus Incentive Compensation Plan on 08/01/2018; one-third (1/3) of the ADSs will vest on each of the first three anniversaries of the grant date.
  • [F3]Options become exercisable as to all 30,000 ADSs on the first anniversary of the 06/28/2017 grant date.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4